• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗HIV二芳基嘧啶-喹诺酮杂合物及其作用模式。

Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.

作者信息

Mao Tian-Qi, He Qiu-Qin, Wan Zheng-Yong, Chen Wen-Xue, Chen Fen-Er, Tang Gang-Feng, De Clercq Erik, Daelemans Dirk, Pannecouque Christophe

机构信息

Department of Chemistry, Fudan University, Shanghai 200433, People's Republic of China; Institute of Biomedical Science, Fudan University, Shanghai 200433, People's Republic of China.

Department of Chemistry, Fudan University, Shanghai 200433, People's Republic of China.

出版信息

Bioorg Med Chem. 2015 Jul 1;23(13):3860-8. doi: 10.1016/j.bmc.2015.03.037. Epub 2015 Apr 6.

DOI:10.1016/j.bmc.2015.03.037
PMID:25907370
Abstract

A molecular hybridization approach is a powerful tool in the design of new molecules with improved affinity and efficacy. In this context, a series of diarylpyrimidine-quinolone hybrids were synthesized and evaluated against both wt HIV-1 and mutant viral strains. The most active hybrid 5a displayed an EC50 value of 0.28±0.07μM against HIV-1 IIIB. A couple of enzyme-based assays clearly pinpoint a RT-targeted mechanism of action. Docking studies revealed that these hybrids could be well located in the NNIBP of HIV-1 RT despite the bulky and polar properties of a quinolone 3-carboxylic acid moiety in the molecules.

摘要

分子杂交方法是设计具有更高亲和力和效力的新分子的有力工具。在此背景下,合成了一系列二芳基嘧啶 - 喹诺酮杂合物,并针对野生型HIV-1和突变病毒株进行了评估。活性最高的杂合物5a对HIV-1 IIIB的EC50值为0.28±0.07μM。几项基于酶的测定清楚地确定了一种靶向逆转录酶的作用机制。对接研究表明,尽管分子中的喹诺酮3-羧酸部分具有庞大且极性的性质,但这些杂合物仍可很好地定位在HIV-1逆转录酶的非核苷类抑制剂结合口袋中。

相似文献

1
Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.抗HIV二芳基嘧啶-喹诺酮杂合物及其作用模式。
Bioorg Med Chem. 2015 Jul 1;23(13):3860-8. doi: 10.1016/j.bmc.2015.03.037. Epub 2015 Apr 6.
2
Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.作为具有改善耐药性的强效HIV-1非核苷类逆转录酶抑制剂的二芳基嘧啶-喹诺酮杂化物的结构修饰
Curr Pharm Des. 2016;22(46):6982-6987. doi: 10.2174/1381612823666161122125657.
3
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.作为HIV-1抑制剂的二芳基嘧啶与二酮酸杂合物的设计与合成
Bioorg Med Chem Lett. 2017 Apr 15;27(8):1640-1643. doi: 10.1016/j.bmcl.2017.03.009. Epub 2017 Mar 7.
4
Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.嘧啶和喹诺酮缀合物的合成作为HIV逆转录酶和整合酶双重抑制剂的支架。
Bioorg Med Chem Lett. 2008 Feb 15;18(4):1293-6. doi: 10.1016/j.bmcl.2008.01.025. Epub 2008 Jan 11.
5
Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.BP-O-DAPY 和 O-DAPY 衍生物作为非核苷 HIV-1 逆转录酶抑制剂的分子设计、合成与生物评价。
Eur J Med Chem. 2013 Jul;65:134-43. doi: 10.1016/j.ejmech.2013.04.052. Epub 2013 May 3.
6
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.具有改善耐药性的HIV-1逆转录酶非核苷抑制剂的设计。1.
J Med Chem. 2004 Nov 18;47(24):5912-22. doi: 10.1021/jm040071z.
7
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.具有改善耐药性的HIV-1逆转录酶非核苷抑制剂的设计。2.
J Med Chem. 2004 Nov 18;47(24):5923-36. doi: 10.1021/jm040072r.
8
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.CHX-DAPYs作为HIV-1非核苷类逆转录酶抑制剂的合成及生物学评价
Bioorg Med Chem. 2014 Jun 15;22(12):3220-6. doi: 10.1016/j.bmc.2014.03.020. Epub 2014 Mar 27.
9
Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.新型二芳基嘧啶类似物的合成及其对1型人类免疫缺陷病毒的抗病毒活性。
J Med Chem. 2005 Mar 24;48(6):2072-9. doi: 10.1021/jm040838n.
10
Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.作为HIV-1逆转录酶非核苷抑制剂的二氨基嘧啶-二苯醚杂化物的合成及生物学评价
Bioorg Med Chem. 2015 Feb 1;23(3):624-31. doi: 10.1016/j.bmc.2014.11.032. Epub 2014 Nov 27.

引用本文的文献

1
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors.基于生物电子等排体原理设计具有口服活性、安全性高且广谱的联苯 - DAPY衍生物作为高效HIV-1非核苷类逆转录酶抑制剂
Acta Pharm Sin B. 2025 Aug;15(8):4115-4136. doi: 10.1016/j.apsb.2025.06.016. Epub 2025 Jun 24.
2
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.利用配体亲和力和性质:新型苯甲酰胺型 cereblon 配体的发现及其在 PROTACs 设计中的应用。
J Med Chem. 2023 Nov 9;66(21):14513-14543. doi: 10.1021/acs.jmedchem.3c00851. Epub 2023 Oct 30.
3
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications.
作为治疗艾滋病潜在药物的杂合分子:设计与应用
Pharmaceuticals (Basel). 2022 Aug 31;15(9):1092. doi: 10.3390/ph15091092.
4
Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel LDHA Inhibitors.新型嘧啶-喹诺酮杂合物作为新型乳酸脱氢酶A(LDHA)抑制剂的设计与合成
Pharmaceuticals (Basel). 2022 Jun 24;15(7):792. doi: 10.3390/ph15070792.
5
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.HIV-1逆转录酶/整合酶双重抑制剂:近期进展及构效关系研究综述
Iran J Pharm Res. 2021 Spring;20(2):333-369. doi: 10.22037/ijpr.2021.115446.15370.
6
Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years.非核苷类逆转录酶抑制剂(NNRTIs)的发展:我们的二十年历程。
Acta Pharm Sin B. 2020 Jun;10(6):961-978. doi: 10.1016/j.apsb.2019.11.010. Epub 2019 Nov 21.